Latest Alligator Bioscience News & Updates

See the latest news and media coverage for Alligator Bioscience. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Alligator Bioscience

Clinical-stage biotechnology company developing tumor-directed cancer immunotherapies

alligatorbioscience.se
Headquarters
Lund, Sweden
Founded year
2001
Company type
Public company
Number of employees
25–50

Latest news about Alligator Bioscience

Company announcements

  • Alligator Bioscience

    Alligator Bioscience announces Q1 2026 interim report call

    The call is on Tuesday 5 May 2026 at 13:00 CEST (07:00 EDT). The report is published at 08:00 CEST that day.

  • Alligator Bioscience

    Alligator Bioscience announces new mitazalimab data presentation at AACR 2026

    Data from Phase 1 trial with IRE in pancreatic cancer patients shows increased T-cell reactivity to neoantigens. Presentation is on April 20, 2026.

  • Alligator Bioscience

    Alligator Bioscience updates on mitazalimab

    Alligator explores phase 3 development options for mitazalimab in pancreatic cancer and signs letter-of-intent with Unicancer for a potential global study. No decisions taken yet.

  • Alligator Bioscience

    Alligator Bioscience's Nomination Committee proposes Board re-elections and elections

    Proposes re-electing Hans-Peter Ostler and Denise Goode, electing Anna Törner and Jörg Möller as ordinary members, and Ostler as Chairman. Eva Sjökvist Saers declines re-election.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Alligator Bioscience

Track Alligator Bioscience and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Alligator Bioscience competitors & trending companies

Browse news for competitors to Alligator Bioscience and other trending companies.